Pfizer-BioNTech Submit Request for Emergency Use of Pediatric COVID-19 Vaccine
The Companies recently submitted data from a phase 2/3 trial that included 2268 pediatric participants.
Diana Ernst, RPh
Editorial Director
Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.
